Ebola drug trials start as 20,000 victims forecast By: CNBC.com News September 23, 2014 at 10:41 AM EDT The world's attention may have shifted to U.S. airstrikes on Syria, but West Africa continues to be ravaged by the worst outbreak of Ebola. Read More >> Related Stocks: Sarepta Therapeutics